UNIGE document Scientific Article
previous document  unige:20457  next document
add to browser collection

Maladies cardiovasculaires, antiagrégants, anticoagulants et risque hémorragique

Eusebio, Jorge
Published in Revue médicale suisse. 2010, vol. 6, no. 267, p. 1942, 1944-1946, 1948-1950
Abstract If the benefits of antiplatelet and anticoagulant therapies are well established, bleeding complications appear underestimated in trials in comparison to their real-life incidence. Also, a large number of patients receive various associations of antiplatelet or anticoagulant treatments, while the benefit of some associations is not firmly established and data about their safety are missing. Identifying patients at high risk of bleeding is essential to define appropriate strategies. In this article we discuss the risk-benefit of various antiplatelet and anticoagulant molecules taken individually or in combination. An overview of the main clinical scores available to stratify the risk of bleeding is presented.
Keywords Anticoagulants/administration & dosage/*adverse effectsHemorrhage/*chemically inducedHumansMyocardial Infarction/*prevention & controlPlatelet Aggregation Inhibitors/administration & dosage/*adverse effectsRisk AssessmentStroke/*prevention & control
PMID: 21125726
Full text
This document has no fulltext available yet, but you can contact its author by using the form below.
Research groups Geneva Platelet Group (13)
Acquisition de l'expertise médicale (662)
(ISO format)
EUSEBIO, Jorge et al. Maladies cardiovasculaires, antiagrégants, anticoagulants et risque hémorragique. In: Revue médicale suisse, 2010, vol. 6, n° 267, p. 1942, 1944-1946, 1948-1950. https://archive-ouverte.unige.ch/unige:20457

247 hits

0 download


Deposited on : 2012-05-22

Export document
Format :
Citation style :